NCT03370081 (CAPNOSSPI) is a NA clinical trial of CAPNOGRAPHY in VENTILATION, sponsored by University Hospital, Bordeaux.

Who is sponsoring NCT03370081?

NCT03370081 is sponsored by University Hospital, Bordeaux.

What drugs are being tested in NCT03370081?

Interventions in NCT03370081: CAPNOGRAPHY.

What condition does NCT03370081 study?

NCT03370081 studies VENTILATION, Capnography.

Is NCT03370081 still recruiting?

NCT03370081 is currently completed. Last updated 16 October 2018.

Last reviewed 2018-10-16 · How we verify

NCT03370081: CAPNOSSPI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Capnometry Monitoring in Post Anesthesia Care Unit

Completed NA Last updated 16 October 2018

What this trial tests

NA trial testing CAPNOGRAPHY in VENTILATION in 53 participants. Completed in 1 June 2018.

Timeline

15 January 2018

Primary endpoint
1 May 2018

1 June 2018

Quick facts

Lead sponsor	University Hospital, Bordeaux
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	diagnostic
Enrollment	53
Start date	15 January 2018
Primary completion	1 May 2018
Estimated completion	1 June 2018
Sites	1 location across France

Drugs / interventions tested

CAPNOGRAPHY

Conditions studied

VENTILATION — all drugs for VENTILATION →
Capnography — all drugs for Capnography →

Sponsor

University Hospital, Bordeaux

Who can join

Adults 18 to 90, any sex, with VENTILATION or Capnography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is few information about the best capnometry value in recovery room for intubated awakening patients. Furthermore, capnometry values could influence ventilation applied by nurses on these patients. The aim of this study is to observe the effects of capnometry monitoring on intubated awakening patients in recovery room.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of capnometry monitoring during recovery in the post-anaesthesia care unit: a randomized controlled trial in adults (CAPNOSSPI).
Potvin J, Etchebarne I, Soubiron L, Biais M, et al · · 2022 · cited 3× · PMID 33550546 · DOI 10.1007/s10877-021-00661-9

Verify or expand the search:

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03370081 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
Last refreshed: 16 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03370081.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing